Literature DB >> 21511831

Inhibitory interactions between BK and JC virus among kidney transplant recipients.

Xingxing S Cheng1, Daniel L Bohl, Gregory A Storch, Caroline Ryschkewitsch, Monique Gaudreault-Keener, Eugene O Major, Parmjeet Randhawa, Karen L Hardinger, Daniel C Brennan.   

Abstract

BK and JC polyomaviruses can reactivate after transplantation, causing renal dysfunction and graft loss. The incidence of JC reactivation after renal transplant is not well understood. Here, we characterized JC reactivation using samples collected during the first year after transplantation from 200 kidney recipients. We detected BK and JC viruses in the urine of 35 and 16% of transplant recipients, respectively. The median viral load in the urine was 400 times higher for BK virus than JC virus. The presence of BK viruria made concurrent JC viruria less likely: JC viruria was detected in 22% of non-BK viruric recipients compared with 4% of BK viruric recipients (P=0.001). The co-detection rate was 1.5%, which is less than the expected 5.6% if reactivation of each virus was independent (P=0.001). We did not observe JC viremia, JC nephropathy, or progressive multifocal leukoencephalopathy. The onset of JC viruria was associated with donor, but not recipient, JC-specific antibody in a titer-dependent fashion and inversely associated with donor and recipient BK-specific antibody. Donor and recipient JC seropositivity did not predict BK viruria or viremia. In conclusion, among renal transplant recipients, infection with one polyomavirus inversely associates with infection with the other.
Copyright © 2011 by the American Society of Nephrology

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511831      PMCID: PMC3269895          DOI: 10.1681/ASN.2010080877

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  23 in total

1.  Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients.

Authors:  Y Yogo; T Kitamura; C Sugimoto; K Hara; T Iida; F Taguchi; A Tajima; K Kawabe; Y Aso
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  High incidence of urinary JC virus excretion in nonimmunosuppressed older patients.

Authors:  T Kitamura; Y Aso; N Kuniyoshi; K Hara; Y Yogo
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

3.  Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.

Authors:  R S Hamilton; M Gravell; E O Major
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.

Authors:  Raphael P Viscidi; Dana E M Rollison; Emma Viscidi; Barbara Clayman; Elizabeth Rubalcaba; Richard Daniel; Eugene O Major; Keerti V Shah
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients.

Authors:  A Azzi; S Cesaro; D Laszlo; K Zakrzewska; S Ciappi; R De Santis; R Fanci; G Pesavento; E Calore; A Bosi
Journal:  J Clin Virol       Date:  1999-10       Impact factor: 3.168

6.  Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction.

Authors:  R R Arthur; S Dagostin; K V Shah
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

7.  BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.

Authors:  Emilio Ramos; Cinthia B Drachenberg; Miguel Portocarrero; Ravinder Wali; David K Klassen; Jeffrey C Fink; Alan Farney; Hans Hirsch; John C Papadimitriou; Charles B Cangro; Matthew R Weir; Stephen T Bartlett
Journal:  Clin Transpl       Date:  2002

8.  Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.

Authors:  S D Gardner; E F MacKenzie; C Smith; A A Porter
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

9.  Human polyomavirus infections with JC virus and BK virus in renal transplant patients.

Authors:  T F Hogan; E C Borden; J A McBain; B L Padgett; D L Walker
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

10.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.

Authors:  Hans H Hirsch; Wendy Knowles; Michael Dickenmann; Jakob Passweg; Thomas Klimkait; Michael J Mihatsch; Jürg Steiger
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

View more
  21 in total

1.  JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease.

Authors:  Etty Kruzel-Davila; Jasmin Divers; Gregory B Russell; Zipi Kra-Oz; Moran Szwarcwort Cohen; Carl D Langefeld; Lijun Ma; Douglas S Lyles; Pamela J Hicks; Karl L Skorecki; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

2.  Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance.

Authors:  Shimon Kusne; Regis A Vilchez; Preeti Zanwar; Jorge Quiroz; Marek J Mazur; Raymond L Heilman; David Mulligan; Janet S Butel
Journal:  J Infect Dis       Date:  2012-07-16       Impact factor: 5.226

3.  JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans.

Authors:  Barry I Freedman; Amy L Kistler; Peter Skewes-Cox; Don Ganem; Mitzie Spainhour; Jolyn Turner; Jasmin Divers; Carl D Langefeld; Mariana Murea; Pamela J Hicks; Ashok K Hemal; James A Snipes; Lihong Zhao; Johanna R Abend; Douglas S Lyles; Lijun Ma; Karl L Skorecki
Journal:  Nephrol Dial Transplant       Date:  2018-11-01       Impact factor: 5.992

4.  Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation.

Authors:  Michael E Seifert; Muthukumar Gunasekaran; Timothy A Horwedel; Reem Daloul; Gregory A Storch; Thalachallour Mohanakumar; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

Review 5.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

6.  BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients.

Authors:  Francesca Rossi; Xiuhong Li; Lisa Jacobson; Andrew J Levine; Yue Chen; Frank J Palella; Joseph Margolick; Raphael Viscidi
Journal:  Virology       Date:  2015-09-07       Impact factor: 3.616

7.  JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study.

Authors:  Britta Höcker; Julia Tabatabai; Lukas Schneble; Jun Oh; Florian Thiel; Lars Pape; Krisztina Rusai; Rezan Topaloglu; Birgitta Kranz; Günter Klaus; Nikoleta Printza; Onder Yavascan; Alexander Fichtner; Kai Krupka; Thomas Bruckner; Rüdiger Waldherr; Michael Pawlita; Paul Schnitzler; Hans H Hirsch; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2018-07-30       Impact factor: 3.714

8.  JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.

Authors:  Jasmin Divers; Marina Núñez; Kevin P High; Mariana Murea; Michael V Rocco; Lijun Ma; Donald W Bowden; Pamela J Hicks; Mitzie Spainhour; David A Ornelles; Steven B Kleiboeker; Kara Duncan; Carl D Langefeld; Jolyn Turner; Barry I Freedman
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

9.  A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient.

Authors:  Seweryn Bialasiewicz; Gareth Hart; Kimberly Oliver; Shruti P Agnihotri; Igor J Koralnik; Raphael Viscidi; Michael D Nissen; Theo P Sloots; Michael T Burke; Nicole M Isbel; John Burke
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

Review 10.  A review on JC virus infection in kidney transplant recipients.

Authors:  Serena Delbue; Mariano Ferraresso; Luciana Ghio; Camilla Carloni; Silvia Carluccio; Mirco Belingheri; Alberto Edefonti; Pasquale Ferrante
Journal:  Clin Dev Immunol       Date:  2013-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.